Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Non Operating Income (2016 - 2026)

Updated

Grace Therapeutics' Non Operating Income was $153,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 90.4% from $1.59 million a year earlier but up 20.5% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Non Operating Income (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Grace Therapeutics' Non Operating Income was $546,000 through Sep 30, 2026, down 82.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.58 million, down 59.5% from FY2025.

  • In earlier fiscal years, Non Operating Income was $3.91 million in FY2025, -$1.83 million in FY2024, $184,000 in FY2023 (-96.4%) and $5.12 million in FY2022.
  • Quarterly Non Operating Income has moved between -$1.63 million (fiscal Q2 2024) and $2.8 million (fiscal Q4 2025) over five years.
  • Per Business Quant data, GRCE's Non Operating Income in the three fiscal quarters before Q2 2027 was $127,000 (Q1 2027), $132,000 (Q4 2026) and $134,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -130.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 153,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 153,000.00
Jun 30, 2026 127,000.00
Mar 31, 2026 132,000.00
Dec 31, 2025 134,000.00
Sep 30, 2025 1.59 Mn
Jun 30, 2025 -272,000.00
Mar 31, 2025 2.80 Mn
Dec 31, 2024 -1.06 Mn
Sep 30, 2024 547,000.00
Jun 30, 2024 1.62 Mn
Mar 31, 2024 -792,000.00
Dec 31, 2023 444,000.00
Sep 30, 2023 -1.63 Mn
Jun 30, 2023 142,000.00
Mar 31, 2023 115,000.00
Dec 31, 2022 82,000.00
Sep 30, 2022 24,000.00
Jun 30, 2022 -36,000.00
Mar 31, 2022 -149,000.00
Dec 31, 2021 696,000.00
API Access

Grace Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY